Merck’s New COVID Pill Is a Disaster
Via Mercola Story at-a-glance An advisory panel to the U.S. Food and Drug Administration voted to grant emergency authorization to Merck’s oral COVID-19 pill molnupiravir (Lagevrio) — by a narrow 13-to-10 margin Among those who received the drug, the rate
Read More